Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the ...

Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

Cannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive ...

Genentech signs $105M upfront deal with Orionis Biosciences to develop molecular glue cancer drugs, with potential milestones ...

With the election of President Donald Trump, the conflict over glyphosate’s risks and benefits entered a new realm of ...

RevivBio, a trailblazing biotech company Redefining Biologics and Biosensors development, welcomes Dr. Ron Meeusen to its Board of Directors. Dr. Meeusen is a renowned leader in biotechnology, with a ...

Federal regulations govern which pesticides can be used and give specific directions for applying them. Ignoring those ...

Cannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive ...

However, advances in biotechnology are creating new opportunities ... End users include the food and beverage, industrial and chemical, healthcare, and personal and home care sectors.

ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp.

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...